Viveve Medical Statistics
Share Statistics
Viveve Medical has 42.90M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 42.90M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 10.72M |
| Failed to Deliver (FTD) Shares | 1.27K |
| FTD / Avg. Volume | 57% |
Short Selling Information
The latest short interest is 374.24K, so 0.87% of the outstanding shares have been sold short.
| Short Interest | 374.24K |
| Short % of Shares Out | 0.87% |
| Short % of Float | 3.49% |
| Short Ratio (days to cover) | 4.15 |
Valuation Ratios
The PE ratio is -0.52 and the forward PE ratio is null.
| PE Ratio | -0.52 |
| Forward PE | null |
| PS Ratio | 1.79 |
| Forward PS | 0 |
| PB Ratio | 0.76 |
| P/FCF Ratio | -0.86 |
| PEG Ratio | n/a |
Enterprise Valuation
Viveve Medical Inc. has an Enterprise Value (EV) of -2.31M.
| EV / Earnings | 0.1 |
| EV / Sales | -0.36 |
| EV / EBITDA | 0.12 |
| EV / EBIT | 0.11 |
| EV / FCF | 0.17 |
Financial Position
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.34.
| Current Ratio | 4.91 |
| Quick Ratio | 4.58 |
| Debt / Equity | 0.34 |
| Total Debt / Capitalization | 25.38 |
| Cash Flow / Debt | -2.51 |
| Interest Coverage | -21.55 |
Financial Efficiency
Return on equity (ROE) is -1.46% and return on capital (ROIC) is -106.82%.
| Return on Equity (ROE) | -1.46% |
| Return on Assets (ROA) | -0.85% |
| Return on Capital (ROIC) | -106.82% |
| Revenue Per Employee | 136.72K |
| Profits Per Employee | -468.66K |
| Employee Count | 47 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 3.94 |
Taxes
| Income Tax | 256.00K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -0.72, so Viveve Medical 's price volatility has been lower than the market average.
| Beta | -0.72 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0 |
| 200-Day Moving Average | 0 |
| Relative Strength Index (RSI) | 50.8 |
| Average Volume (20 Days) | 2.23K |
Income Statement
In the last 12 months, Viveve Medical had revenue of $6.43M and earned -$22.03M in profits. Earnings per share was $-2.65.
| Revenue | 6.43M |
| Gross Profit | 620.00K |
| Operating Income | -21.55M |
| Net Income | -22.03M |
| EBITDA | -19.63M |
| EBIT | -21.55M |
| Earnings Per Share (EPS) | -2.65 |
Balance Sheet
The company has $19.16M in cash and $5.35M in debt, giving a net cash position of $13.81M.
| Cash & Cash Equivalents | 19.16M |
| Total Debt | 5.35M |
| Net Cash | 13.81M |
| Retained Earnings | -241.85M |
| Total Assets | 12.15M |
| Working Capital | -1.23M |
Cash Flow
In the last 12 months, operating cash flow was -$12.88M and capital expenditures -$456.00K, giving a free cash flow of -$13.33M.
| Operating Cash Flow | -12.88M |
| Capital Expenditures | -456.00K |
| Free Cash Flow | -13.33M |
| FCF Per Share | -1.32 |
Margins
Gross margin is 9.65%, with operating and profit margins of -335.4% and -342.78%.
| Gross Margin | 9.65% |
| Operating Margin | -335.4% |
| Pretax Margin | -338.8% |
| Profit Margin | -342.78% |
| EBITDA Margin | -305.51% |
| EBIT Margin | -335.4% |
| FCF Margin | -207.5% |
Dividends & Yields
VIVE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | -310815.85% |
Analyst Forecast
Currently there are no analyst rating for VIVE.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 2, 2020. It was a backward split with a ratio of 1:10.
| Last Split Date | Dec 2, 2020 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -35.14 |
| Piotroski F-Score | 4 |